Companies › Cigna · Global Markets & Policy
Cigna
- NYSE: CI
U.S.-listed company (NYSE: CI) that the SEC classifies under industry code 6324, "Hospital & Medical Service Plans".
Next earnings report: Nov 5, 2026. Cigna quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $6.6M, purchases $0. All Cigna insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Everett Neville See Remarks | Open-market sale 10b5-1 plan | 617 | $284.05 | $175K | Form 4 ↗ |
| Aug 18, 2026 | Nicole S Jones See Remarks | Open-market sale 10b5-1 plan | 2,677 | $279.61 | $749K | Form 4 ↗ |
| Aug 4, 2026 | Nicole S Jones See Remarks | Open-market sale 10b5-1 plan | 19,436 | $276.27 | $5.4M | Form 4 ↗ |
| Jun 12, 2026 | Jamie G Kates Chief Accounting Officer | Open-market sale | 899 | $298.61 | $268K | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $180.5B | $195.3B | $247.1B | $274.9B |
| Operating income | $8.4B | $8.5B | $9.4B | $9.2B |
| Net income | — | $5.2B | $3.4B | $6.0B |
| Diluted EPS | $21.41 | $17.39 | $12.12 | $22.18 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-09 · 8-K — Director or officer change
- 2026-09-30 · 8-K — Regulation FD disclosure
- 2026-07-30 · 10-Q
- 2026-07-30 · 8-K — Results of operations
- 2026-05-13 · 8-K — Regulation FD disclosure
- 2026-04-30 · 10-Q
- 2026-04-30 · 8-K — Results of operations
- 2026-04-27 · 8-K — Shareholder vote results
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.